However, despite of the effective repressive role of IL1 antagonists (such as sIL-R or IL1RA) on the growth of LCs in in vitro culture [38–40], inhibition of IL1 signaling might not be able to successfully repress AML in vivo due to compensation by TNF-stimulated signaling. This evidence concerns the gene IL1B and acute myeloid leukemia.